Jean-Michel Gries

Jean-Michel Gries is a highly experienced executive in the pharmaceutical and biotechnology sectors, currently serving as President and COO of Aitia since May 2021 and as Chairman of the Scientific Advisory Board and Chief R&D Officer at Kodikaz Therapeutic Solutions, Inc. since 2019. Gries has held notable leadership roles including President & Head of Research at Hengenix Biotech from August 2021 to September 2023, and VP & SBU Leader at Parexel, managing global business unit operations with a significant team. Additional experience includes senior roles at Covance, Alcon, Paramount BioSciences, Immunetrics, and Roche, with a proven track record in research and development, strategic management, and drug development. Educational credentials include a PhD in Applied Mathematics & Pharmacokinetics and an MBA in finance and entrepreneurial leadership from prestigious institutions.